Completed NA INTERVENTIONAL 2-arm NCT03078712

Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study (ANDROMEDA)

Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study

Sponsor: Pontificia Universidad Catolica de Chile

Conditions Hyperlactatemia Peripheral Perfusion Septic Shock

Interventions Lactate guided resuscitation Peripheral Perfusion guided resuscitation

Updated 6 times since 2017 Last updated: Jul 19, 2018 Started: Mar 1, 2017 Primary completion: Mar 15, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Hyperlactatemia and Peripheral Perfusion, this trial is completed. The trial is conducted by Pontificia Universidad Catolica de Chile and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Aug 2018 [monthly]

Recruiting NA

▶ Show 1 earlier version

Apr 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pontificia Universidad Catolica de Chile

Data source: Pontificia Universidad Catolica de Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile